Key players are manufacturing urinary incontinence treatment drugs with advanced treatment methods in emerging economies, and this isexpected to boost demand for urinary incontinence treatment drugs market in the Middle East region. For instance, in December 2022, according to an article published by PubMed Central, a study was conducted in the United Arab Emirates which showed that the quality of life was impaired in an estimated 90% of patients with urinary incontinence. Therefore, the increasing burden of urinary incontinence among women and the aging population increases demand for urinary incontinence treatment drugs.
Global Urinary Incontinence Treatment Drugs Market - Key Players
Major players operating in the global urinary incontinence treatment drugs market include Johnson & Johnson, Pfizer Inc., Astellas Pharma, Inc., Allergan, Inc., Takeda Pharmaceutical Company Limited, Merck & Co., Inc., Sanofi S.A., IXALTIS, Bayer AG, elicept Therapeutics, Taiho Pharmaceutical, Cook MyoSite and Urovant Sciences GmbH.
Urinary Incontinence Treatment Drugs Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients